Coronavirus cases are increasing in Mongolia, where more than half of the population are fully vaccinated. This prompted a new focus on the efficacy of the main vaccine developed by China’s Sinopharm.
Mongolia reported 1,312 new coronavirus cases on Wednesday as the country’s total number of cases nears 70,000, almost all recorded since January, according to the New York Times database, adding more than one percent of the daily new infections. 70 in the last two weeks
Landlocked countries have become freakish in the global race for vaccines among developing countries. by obtaining sufficient quantities for the eligible population Thanks to the strategic location between Russia and China. Two vaccine giants with global ambitions Mongolia has signed an agreement for 4.3 million doses of the Sinopharm vaccine and one million doses of the Russian Sputnik V vaccine. Although only 60,000 doses of Sputnik have arrived.
Chinese vaccines, such as those made by Sinopharm and other company Sinovac, use coronaviruses. that does not work to stimulate an immune response in the body. This research has shown to be less effective than vaccines developed by pharmaceutical companies Pfizer and Moderna, which use newer mRNA technology.
Sinopharm’s vaccine was initially under scrutiny due to a lack of transparency in late-stage trial data. Vaccines face more questions after the Seychelles island nation heavily relies on Sinopharm to inoculate its population. It was found that the number of patients was also increased. Although most people are not seriously ill.
Ben Cowling, an epidemiologist and biostatistician at the University of Hong Kong School of Public Health, said: “Inactivated vaccines like Sinovac and Sinopharm are ineffective against infection. But it is very effective in preventing serious diseases.
“Although Mongolia is experiencing a rapid increase in the number of infections and cases, But my expectation is that there will be no mass hospitalizations,” he added.
And some viruses may spread quickly enough to cause concern, even in countries where most of the population have effective vaccinations for them: the UK is facing an increasing number of cases linked to the delta variant, though. More than half of the adult population will be fully vaccinated. Mostly with shots from AstraZeneca and Pfizer.
Still, the wave of infections has raised questions in Mongolia why the government relied on the Sinopharm shooting rather than a vaccine that has proven to be more effective. It comes as Mongolians head to Wednesday’s elections to vote for the president. The first election since the constitution was amended to limit the president to six years of office. The prime minister is the head of government and has executive powers.
Last year, Mongolia was one of the few countries in the world with no local coronavirus cases. But the November outbreak changed that. A political crisis and protests over the outbreak’s mismanagement led the prime minister to resign in January.
New Prime Minister Oyun-Erdene Luvsannamsrai It has pledged to revive a slumping economy and end social constraints affecting businesses. A new wave of lawsuits could threaten this pledge.